Thunder guard Nikola Topic diagnosed with testicular cancer and undergoing chemotherapy

30.10.2025    WTOP    2 views
Thunder guard Nikola Topic diagnosed with testicular cancer and undergoing chemotherapy

OKLAHOMA CITY AP Oklahoma City Thunder guard Nikola Topic has been diagnosed with testicular cancer and is undergoing chemotherapy Sam Presti the crew s general manager informed the finding on Thursday Topic had a testicular procedure earlier in the month The Thunder announced at the time he d be out for at least four weeks Presti mentioned doctors are extremely positive about his long-term outlook He commented Topic has been working out throughout the process and didn t want the evaluation revealed until after he started medicine He has all the tools that you could ask for somebody to take on and conquer the situation Presti declared Topic a first-round pick in missed the entire - season while recovering from a torn ACL He played in summer league this year and started a preseason contest against Charlotte posting points and seven assists in Oklahoma City s - win Topic was expected to be an critical addition to a squad that otherwise changed very little after winning the NBA title last season AP NBA https apnews com hub NBA Source

Similar News

Bengals host Bears with both teams looking to boun
Bengals host Bears with both teams looking to bounce back after tough losses last week

Chicago (4-3) at Cincinnati (3-5) Sunday, 1 p.m. EST, CBS. BetMGM line: Bears by 2 1/2. Against the ...

30.10.2025 0
Read More
Gov. Healey launches SNAP Resource Hub, announces $8M in food aid amid federal benefit freeze
Gov. Healey launches SNAP Resource Hub, announces $8M in food aid amid federal benefit freeze

Massachusetts doubles food bank aid and launches a SNAP Resource Hub to help families facing hunger ...

30.10.2025 0
Read More
Indigenous filmmakers have their lenses aimed
Indigenous filmmakers have their lenses aimed

November is National Native American Heritage Month—a period when public attention is briefly direct...

30.10.2025 0
Read More